Urging the legislative council to assign the topic of whether the use of hyperbaric oxygen therapy in Indiana is being sufficiently regulated.
Summary
Senate Resolution 76 urges the Indiana Legislative Council to assign a study committee to examine whether hyperbaric oxygen therapy (HBOT) is sufficiently regulated in Indiana. The resolution describes HBOT as a medical treatment that uses a hyperbaric chamber to increase oxygen absorption and notes that it is used to promote healing, fight infection, and reduce inflammation.
The resolution also references existing Indiana administrative rules governing HBOT, including requirements that the therapy be clinically practical and not replace other standard successful treatments. It further notes that HBOT use in Indiana requires a treatment plan submission to the Indiana Department of Health, along with a physician prescription and verification of eligibility. The measure does not itself change substantive law; instead, it seeks a legislative study of the current regulatory framework and whether additional oversight is needed to protect patients and practitioners.
Impact
SR0076 would not directly amend the Indiana Code or administrative rules. Its practical effect would be to place the regulation of hyperbaric oxygen therapy on the Legislative Council’s agenda for possible study by an interim committee, which could lead to recommendations for future legislation or regulatory changes affecting providers, physicians, clinics, and patients using HBOT in Indiana.
Sentiment
The available text suggests a generally cautious and supportive sentiment toward review of the issue. The resolution frames the study as a patient-safety and practitioner-safety measure, indicating concern that current regulation may need closer examination. No committee testimony or recorded votes are provided, so there is no evidence of formal opposition or support beyond the resolution’s own rationale.
Contention
The main point of contention implied by the resolution is whether Indiana’s current HBOT rules are sufficient or whether they leave gaps that warrant further legislative scrutiny. Supporters of the study appear focused on safety, clinical appropriateness, and oversight of treatment plans and eligibility verification. Any opposing view would likely center on whether existing administrative requirements already provide adequate regulation and whether additional study is necessary, but no direct opposition is documented in the provided materials.